The molecular signals that regulate growth and branching of the ureteric bud during formation of the renal collecting system are largely undefined. Members of the bone morphogenetic protein (BMP) family signal through the type I BMP receptor ALK3 to inhibit ureteric bud and collecting duct cell morphogenesis in vitro. We investigated the function of the BMP signaling pathway in vivo by generating a murine model of ALK3 deficiency restricted to the ureteric bud lineage (Alk3 UBϪ/Ϫ mice). At the onset of branching morphogenesis, Alk3 UBϪ/Ϫ kidneys are characterized by an abnormal primary (1Њ) ureteric bud branch pattern and an increased number of ureteric bud branches. However, during later stages of renal development, Alk3 UBϪ/Ϫ kidneys have fewer ureteric bud branches and collecting ducts than wild-type kidneys. Postnatal Alk3 UBϪ/Ϫ mice exhibit a dysplastic renal phenotype characterized by hypoplasia of the renal medulla, a decreased number of medullary collecting ducts, and abnormal expression of ␤-catenin and c-MYC in medullary tubules. In summary, normal kidney development requires ALK3-dependent BMP signaling, which controls ureteric bud branching.
Formation of the renal collecting system begins via branching morphogenesis, defined as growth and branching of the ureteric bud (UB) and its branches. The first branching event is invariably a symmetrical bifurcation of the UB at its tip, 1 which generates two daughter branches, termed 1°UB branches because of their spatial attachment to the initial UB outgrowth. Subsequent branch generations are formed by a combination of terminal bifid and lateral branching. The molecular signals that control UB branch patterning, including the inhibitory signals that limit both position and number of 1°branches that form off the ureter trunk, remain undefined.
Members of the bone morphogenetic protein (BMP) family of secreted peptide growth factors signal through their activin-like kinase (ALK) type I receptors and downstream Smad effectors to control embryonic tissue development. 2 In the embryonic kidney, two closely related BMPs, BMP2 and BMP4, are expressed in discrete, nonoverlapping domains in the mesenchyme surrounding the tips of the branching UB, and adjacent to the ureter trunk, respectively, 3 whereas the BMP2/4 type I receptor ALK3 is expressed in both the UB and mesenchyme lineages. 4 Exogenous treatment of embryonic kidney explants with either BMP2 or BMP4 potently inhibits branching morphogenesis in vitro, [5] [6] [7] and Bmp4 inhibits ectopic UB outgrowth off the Wolffian duct in vivo. 8 Similarly, ALK3 inhibits UB branching both in vitro and in transgenic mice overexpressing Alk3 in the UB. 9, 10 However, the mechanisms by which BMP-ALK signaling regulates renal branching morphogenesis in vivo are undefined. Here, we used the Cre-loxP system to delete Alk3 in the UB lineage. Our results demonstrate that ALK3 deficiency disrupts UB patterning, resulting in an increased number of 1°UB branches followed by a reduced number of both UB branches and collecting ducts, and postnatal kidney malformation.
RESULTS
During renal embryogenesis, Alk3 mRNA is highly expressed in the Wolffian duct, including its caudal aspect, which is the origin of the UB ( Figure 1A ). After invasion of the UB into the metanephric mesenchyme, Alk3 is expressed in both the UB and mesenchyme (Figure 1 , B and C). Because homozygous inactivation of Alk3 causes embryonic lethality at approximately E8, 11 we used a conditional Alk3 allele (Alk3 C ) and induced excision of exon 2 12 in UB cells using HoxB7Cre-EGFP transgenic mice. 13 In Alk3 UBϪ/Ϫ kidneys, Alk3 mRNA was expressed in the nephrogenic mesenchyme and mesenchymederived structures but was not detected in collecting ducts ( Figure 1 , D through I). In Alk3 UBϪ/Ϫ kidney tissue lysates, ALK3 protein was markedly decreased compared with Wt (wild-type) ( Figure 1L ). E11.5 Alk3 UBϪ/Ϫ kidneys exhibited a marked reduction of phospho-Smad1, an intracellular BMP-ALK3 signaling effector, 14 in UB cells, whereas expression was maintained in metanephric mesenchyme compared with Wt ( Figure 1K versus 1J) . Similarly, phospho-Smad1 protein expression was decreased in tissue lysates of Alk3 UBϪ/Ϫ kidneys ( Figure 1L ). Thus, both ALK3 protein and downstream signaling activity are reduced in Alk3 UBϪ/Ϫ kidneys.
Abnormal Ureteric Bud Branching in ALK3-Deficient Kidneys
Green fluorescent protein (GFP)-fluorescence was used to visualize UB branching in Alk3 UBϪ/Ϫ kidneys. Branch patterns were schematized using color-coded stick figures to classify UB branches according to their spatial orientation relative to the ureter trunk (Figure 2A ). At E11.5, the Wt UB exhibits the archetypal bifid 1°branch pattern ( Figure 2B ), characterized by a ureter trunk (red) and two 1°UB branches (cyan). At E12.5, successive bifid branching of UB tips yielded 2°(violet) and 3°(black) branches, defined by their attachment to 1°and 2°branches, respectively ( Figure 2C ). In contrast to Wt kidneys, a minority of heterozygous Alk3 UBϪ/UBϩ kidneys (two of To analyze the effect of ALK3 deficiency on subsequent branching events, we cultured E12. UBϪ/Ϫ (ϩ48h) kidneys compared with Wt (branch type versus reduction in branch number: 4°(41%), P ϭ 0.0004; 5°(76%), P ϭ 0.0006; 6°(92%), P ϭ 0.001; 7°(100%), P ϭ 0.04). Cumulatively, the total number of UB branches formed in Alk3 UBϪ/Ϫ kidneys was reduced by 22% (P ϭ 0.05).
We analyzed embryonic kidneys immediately after isolation to confirm that the reductions in total UB branch number we observed were independent of organ culture conditions. Histological analysis of E13. UBϪ/Ϫ kidneys compared with Wt (P ϭ 0.002; n ϭ 7 kidneys/group).
We next investigated cellular mechanisms that could mediate ALK3-dependent effects on UB branching. Quantitation of cell proliferation using BrdU incorporation in Alk3 UBϪ/Ϫ kid- BASIC RESEARCH www.jasn.org neys showed similar rates of proliferation in Alk3 UBϪ/Ϫ UB trunks and tips compared with Wt kidneys at E12.5 and E13.5 (P ϭ 0.66 and P ϭ 0.36, respectively) (Supplemental Figures 1  and 2 ). Alk3 UBϪ/Ϫ kidneys also displayed similar, negligible rates of apoptosis compared with Wt as measured by terminal deoxynucleotidyl transferase biotin dUTP nick end labeling (TUNEL) assay (Supplemental Figure 2, F and G) . Thus, neither alterations in the rate of cell proliferation or apoptosis appear to play a significant role in the genesis of the ALK3-deficient phenotype.
To define molecular effectors that might mediate ALK-dependent control of 1°UB branching, we examined expression of genes known to regulate UB branch patterning including Gdnf 15 , Ret 16 , Wnt11 17 , and Sprouty 1 (Spry1) 18 in E11.5 metanephric tissue (Supplemental Figure 3) . The expression patterns of Gdnf and c-Ret mRNAs in the metanephric mesenchyme and UB, respectively, were similar in Alk3 UBϪ/Ϫ metanephric tissue compared with Wt tissue. Similarly, we detected no qualitative difference in the expression of Wnt11 in UB branch tips or Spry1 in the UB epithelium and metanephric mesenchyme in Alk3-deficient tissue. These data imply that Alk3-dependent Bmp signaling acts via genes other than Gdnf, Ret, Wnt11, and Spry1 to regulate early UB branch patterning.
Next, we investigated molecular mechanisms that could underlie decreased ureteric branching observed in Alk3-deficient kidneys. Pax2 is a critical effector of renal branching morphogenesis. 19, 20 ALK3-Deficient kidneys with a moderate branching defect exhibited a marked decrease in Pax2 mRNA expression in the UB lineage, whereas mesenchymal expression did not appear to be affected ( Figure 4, A and B) , whereas expression of Pax2, a marker of both collecting ducts and nephrogenic zone at E18.5, was specifically reduced in the renal medulla of these mice (Figure 4 , C through F). Together, these data suggested that collecting duct number was reduced in Alk3 UBϪ/Ϫ kidneys. Quantitation of anticalbindin 28K -labeled collecting ducts in serial tissue sections revealed a 39% reduction in collecting duct number in Alk3 UBϪ/Ϫ kidneys compared with Wt (P ϭ 0.0001; n ϭ 6 kidneys/group) ( Figure 4, G through I) . 
Adult Alk3 UB؊/؊ Mice Exhibit Severe Medullary Hypoplasia
Postnatal Alk3 UBϪ/Ϫ kidneys (P21) exhibited a dysplastic phenotype characterized by absence of the renal papilla, and medullary hypoplasia ( Figure 5, A and B) . Medullary collecting ducts, identified by calbindin 28K antibody, were dilated and did not form linear arrays characteristic of collecting ducts in Wt mice ( Figure 5, C and D) . Phospho-Smad1 was undetectable in the nuclei of Alk3 UBϪ/Ϫ medullary collecting duct cells ( Figure 5, E and F) , and phospho-Smad1 protein was reduced 52% in Alk3 UBϪ/Ϫ whole kidney lysates ( Figure 5K ), confirming the loss of ALK3-dependent signaling in these kidneys. Malformed collecting ducts of Alk3 UBϪ/Ϫ mice exhibited markers of abnormal renal epithelial tubular differentiation. Cellular expression of ␤-catenin was markedly increased in Alk3 UBϪ/Ϫ kidney tissue sections ( Figure 5 , G and H), corresponding to a 511% increase in ␤-catenin protein in kidney tissue lysates ( Figure 5K ). Remarkably, we detected de novo MYC expression in Alk3 UBϪ/Ϫ medullary collecting duct cell nuclei ( Figure 5 , I and J), and in kidney tissue lysates ( Figure  5K ). Thus, the dysplastic phenotype in adult Alk3 UBϪ/Ϫ kidneys is associated with reduced ALK3-dependent Smad1 signaling, malformation of medullary collecting ducts, and abnormal activation of ␤-catenin and MYC.
DISCUSSION
The experiments reported here demonstrate a critical role for ALK3 during renal development. Deficiency of ALK3 in the UB lineage results in renal malformation associated with a decreased number of collecting ducts and their progenitor UB branches. Remarkably, our analysis of embryonic Alk3 kidneys demonstrates a biphasic branching defect, which manifests as an early increase in the number of 1°and 2°UB branches, but a decrease in the number of subsequent branches formed, resulting in an overall reduction in UB number. These results suggest that ALK3 normally functions to limit UB branching at the earliest stages of branching morphogenesis. Furthermore, loss of ALK3-dependent inhibition during this period interferes with the number of branches that can be subsequently formed.
We previously showed that constitutive activation of ALK3-Smad1 signaling in the UB of transgenic mice also results in decreased UB branching. 10 Although both ALK3 gain-and loss-of-function mouse models exhibit a similar outcome, the mechanisms underlying these outcomes are distinct. The former represents a proof-of-principle model, establishing that constitutive overexpression of ALK3 can inhibit branching morphogenesis. Indeed, the increase in early branching observed in the present loss-of-function model is consistent with results from the overexpression model. However, the ALK3-deficient model also reveals that abnormal early patterning of the UB is deleterious to later branching events, suggesting that the subsequent decreases in UB branching and Previous studies have demonstrated a role for BMPs and BMP inhibitors in regulating UB outgrowth from the Wolffian Duct. Bmp4 ϩ/Ϫ mice exhibit ectopic and supernumerary UB outgrowths from the Wolffian duct. Aberrant outgrowth is associated with abnormal metanephric development. 8 Similarly, homozygous deficiency of gremlin, a BMP inhibitor, causes renal aplasia as a result of failure of UB outgrowth. 21 Interestingly, E12.5 Alk3 UBϪ/Ϫ mice do not exhibit ectopic UB outgrowths along the Wolffian duct, defects observed in Bmp4 ϩ/Ϫ kidneys. Thus, Bmp4-dependent regulation of UB outgrowth at the level of the Wolffian duct appears to be ALK3-independent and may instead be mediated through ALK6 or another ALK receptor. Our results are consistent with a role for ALK3 in transducing BMP2-dependent signals. Bmp2 transcripts are strongly detected in the mesenchymal condensates surrounding actively branching UB tips, as well as weakly in stromal cells adjacent to UB trunk segments. 3 Thus, formation of supernumerary UB branches could be caused by the loss of BMP2-ALK3 inhibition of growth along UB trunk segments and terminal UB branching.
ALK3-deficient E13.5 kidney tissue exhibited variable alterations in Pax2 expression. In mice with a moderate branching defect, a specific reduction of Pax2 expression was observed in the UB lineage. These results suggest that ALK3 signaling regulates Pax2 expression in the UB, possibly at the level of transcription, thereby controlling growth and branching. In contrast, mutants with severe reductions in UB branch number exhibited a marked loss of Pax2 expression in both the UB and mesenchyme cell lineages. Because Pax2 is normally expressed in induced mesenchyme, these results suggest that a failure in UB branching in severely affected mutants disrupts mesenchyme induction in these mice, leading to a loss of induced, Pax2-and WT-1-expressing mesenchyme.
Our results, which demonstrate reduced Pax2 expression in both moderately and severely affected Alk3 mutant kidneys at E13.5, were surprising given the normal levels of Gdnf expression we observed at E11.5 in these mice and the established role of Pax2 in positively regulating Gdnf expression during kidney induction. 22 Severely and moderately affected E13.5 Alk3 mutant kidneys are indistinguishable from each other at earlier stages of development, both groups appearing as trifid structures at E11.5. Thus, it is possible that E11.5 Alk3 mutant kidneys exhibiting normal expression patterns of Gdnf/Ret, Wnt11, and Spry1 represent the cohort of kidneys with a moderate branching defect at E13.5, together with a UB-specific absence of Pax2. In this context, Pax2-dependent expression of Gdnf in the mesenchyme of these Alk3 mutants would be unaffected because mesenchymal Pax2 expression is maintained in these mice. Indeed, complete loss of Pax2 before kidney induction has been shown to be incompatible with renal development, resulting in renal agenesis as a result of a loss of Gdnf-Ret signaling. 22, 23 Alternatively, all Alk3 mutants, regardless of their patterns of Pax2 expression at E13.5, may exhibit normal or near-normal Pax2 expression at E11.5, with the loss of Pax2 expression observed at E13.5 occurring subsequent to initial UB induction, thus explaining the normal expression of Gdnf-Ret at E11.5. Notably, in E16.5 Pax2
ϩ/Ϫ compound hetero- zygote kidneys exhibiting a partial reduction of Pax2 expression, both Gdnf and Ret expression are unaffected, 24 suggesting that the expression of these genes is resilient against moderate reductions in Pax2, and further, that expression of these genes may be regulated by both Pax2-dependent and -independent pathways.
Postnatal ALK3-deficient kidneys are characterized by misexpression of ␤-catenin and MYC. These abnormalities are likely secondary events because we did not observe increased expression of either ␤-catenin or MYC in embryonic kidney tissue and because we have observed increased ␤-catenin and MYC expression in overexpression models of BMP signaling. Both ␤-catenin and MYC are increased by BMP2 treatment in vitro 25 and by constitutive expression of Alk3 in vivo. 10 Collectively, these results suggest that activation of ␤-catenin and MYC in dysplastic Alk3 UBϪ/Ϫ kidneys does not represent a Bmp-dependent disease pathway but rather a final convergent pathway in the pathogenesis of diverse models of cystic renal dysplasia.
Collectively, our results suggest that initial patterning of the UB branch tree is an important determinant of later branching events that give rise to the collecting duct system of the kidney. Further experiments that explore the relationship between 1°U B branch pattern and subsequent branching morphogenetic events will help illuminate the mechanisms that control collecting duct development.
CONCISE METHODS

Mice and Genotyping
HoxB7-Cre-GFP;Alk3 ϩ/Ϫ , Wt, and Alk3 C/C mice were maintained on 129SvJ:C57BL/6 genetic backgrounds and genotyped by PCR. 11, 12 Assessment of Ureteric Bud Branching, Cell Proliferation, and Apoptosis UB branches were imaged by fluorescence microscopy for expression of GFP or FITC-conjugated Dolichos biflorus agglutinin (20 g/ml; Vector Labs, Burlingame, CA). UB branch points were defined as the intersection between three connected branches. 26 Cell proliferation was assayed by incorporation of 5-bromo-2Ј-deoxyuridine (BrdU; Roche, Indianapolis, IN). 5 Apoptosis was assayed using an in situ TUNEL assay. 14 
Quantitation of Collecting Duct Number
Each kidney was serially-sectioned (4 m thick) in its entirety. The number of collecting ducts, identified by anti-calbindin 28K antibodies, was counted as the mean value of that in each of ten tissue sections (five on each side of the deepest section).
Immunohistochemistry, In Situ Hybridization, and Western Blot Analysis Paraffin wax-embedded sections (4 m thick) of embryonic kidney tissue were prepared. 27 Primary antibodies were directed against calbindin 28K (Sigma, St. Louis, MO), phospho-Smad1 (Upstate, Charlottesville, VA), ␤-catenin (Upstate), and c-myc (Cell Signaling, Danvers, MA). RNA in situ hybridization was performed as described, 28 using probes encoding Alk3, Pax2, Wt1, Gdnf, c-Ret, Wnt11, and Spry1. For immunoblotting, primary antibodies were directed against ALK3 (1:250 dilution; Santa Cruz, Santa Cruz, CA), phosphoSmad1 (1:250 dilution), ␤-catenin (1:1000 dilution), c-myc (1:250 dilution), and ␤-actin (1:20,000 dilution; Sigma). Values are presented as mean differences computed from pooled data using a twotailed t test (P Ͻ 0.05).
